News

Camlin Fine Sciences announced that the 33th Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Net profit of Camlin Fine Sciences reported to Rs 88.20 crore in the quarter ended March 2026 as against net loss of Rs 0.72 crore during the previous quarter ended March 2025. Sales declined 1.57% to Rs 424.81 crore in the quarter ended March 2026 as against Rs 431.58 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 27.63 crore in the year ended March 2026 as against net loss of Rs 139.05 crore during the previous year ended March 2025. Sales rose 5.81% to Rs 1723.31 crore in the year ended March 2026 as against Rs 1628.69 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales424.81431.58 -2 1723.311628.69 6 OPM %4.9914.38 -6.2013.26 - PBDT23.5160.10 -61 64.40135.35 -52 PBT2.6942.95 -94 -6.5274.39 PL NP88.20-0.72 LP 27.63-139.05 LP Powered by Capital Market - Live News

The board of Camlin Fine Sciences at its meeting held on 26 May 2026 has approved the appointment of Pankaj Pandey as Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, effective 18 August 2026. Further, the board approved the re-designation of Santosh Parab, currently Chief Financial Officer, as President � Strategy and Global CFO, effective 18 August 2026.

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Camlin Fine Sciences (CFSL) has completed the acquisition of on 27 November 2025, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mn�monique : ALVIN) representing 78,68% of share capital et 84.89% of voting rights of Vinpai, at a price of Euro 3.60 per Vinpai share (block acquisition) from significant shareholders (sellers). Additionally, CFSL was allotted 1,100,000 new ordinary shares of Vinpai on conversion of convertible bonds on 20 October 2025.Following the block acquisition and conversion of convertible bonds, CFSL now holds 83.82% stake in Vinpai`s share capital and 80.86% of its voting rights.On 23 December 2025, CFSL had announced that it would file, by end of February 2026  a simplified cash tender offer (offre publique d`achat simplifi�e) (OPAS) with the French Stock Markets Authority (AMF) for the remaining shares of Vinpai, at the same price as that of the block acquisition, i.e. Euro 3.60 per Vinpai share. However, due to administrative constraints specific to CFSL related to Indian foreign exchange regulations and due to the proximity of the announced publication date of Vinpai`s 2025 annual financial statements on 16 April  2026, CFSL announces that it will have to postpone the filing of its OPAS with the purchase price per Vinpai share under the OPAS remaining at Euro 3.60.Such filing would take place no later than early May 2026 so that the aforementioned Vinpai financial statements may be incorporated into the documentation relating to the OPAS, and into the independent expert`s report.Furthermore, CFSL is looking at the feasible options for restructuring of its group in Europe, to promote synergies among its European subsidiaries and strengthen its presence in Europe. In view of the same, CFSL wishes to keep Vinpai listed.Consequently, CFSL announces that it no longer intends to implement a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.Maintaining this listing will allow Vinpai to retain market visibility and have access to the financial markets, ensuring its debt restructuring and supporting the financing of the project`s development in Europe, that CFSL group may pursue in the future. Powered by Capital Market - Live News